Eligibility depends on multiple factors, including medical history, psychiatric stability, nutritional status, recovery stage, and the presence of eating disorder symptoms or vulnerabilities
Recent comparisons, such as Retatrutide vs tirzepatide, indicate that Retatrutide might provide more substantial weight loss benefits
Transitioning weight loss and obesity treatments from transactional interactions to true chronic condition management is a must for better health outcomes, not an option, said Josh Herring, President and CEO of the Longevity Science Foundation
Over the past two decades, Innerbody Research has helped tens of millions of readers make more informed decisions involving staying healthy and living healthier lifestyles